Ferring Pharmaceuticals is proud to announce the launch of the website www.dryallnight.com…

An international congress has been established by a panel of world leading experts to educate urologists and GPs about the neglected disease area called Nocturia. Nocturia means waking to urinate more than once a night regularly…

On January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed…

More evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…

COPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…

Ferring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…

The Board of Directors of Ferring announced this week that Professor Michael Rosenblatt has been appointed to the Group Board…

Ferring would like to announce that Mr. Aaron Graff has been appointed as Vice President of Global Marketing, Medical Services and Business Development…

Ferring Launches a New No Needle Device at 2nd Ferring International Paediatric Endocrinology Symposium…

The Board of Directors of Ferring announced today that Mr. Bernd Wolff has been appointed as a board member. Wolff becomes an outside director to the board…